Voyager Therapeutics Inc (VYGR) — Free Cash Flow Generation Index

Latest as of March 2024: 0.96x

Voyager Therapeutics Inc (VYGR) has a Free Cash Flow Generation Index of 0.96x as of March 2024. Free cash flow of $56.63 Million represents 1% of operating cash flow ($58.77 Million). Read Voyager Therapeutics Inc balance sheet liabilities for a breakdown of total debt and financial obligations.

FCF Generation Index

0.96x
Free Cash Flow / Operating CF

Free Cash Flow

$56.63 Million
USD

Operating Cash Flow

$58.77 Million
USD

Capital Expenditures

$2.14 Million
USD

Voyager Therapeutics Inc Free Cash Flow Generation Index (2015–2023)

Historical FCF Generation Index trend for Voyager Therapeutics Inc across 3 annual periods. Explore VYGR capital reinvestment ratio to see what proportion of operating cash flow is directed to capital expenditures.

Annual Free Cash Flow Generation for Voyager Therapeutics Inc (2015–2023)

Year-by-year Free Cash Flow Generation Index for Voyager Therapeutics Inc. For the full company profile including market capitalisation, see Voyager Therapeutics Inc (VYGR) total market value.

Year FCG Index Free Cash Flow (USD) Operating CF Capital Expenditures YoY Change
2023 0.96x $74.66 Million $77.92 Million $3.26 Million ▲ +13.9%
2019 0.84x $40.95 Million $48.67 Million $7.72 Million ▼ -13.7%
2015 0.98x $40.27 Million $41.30 Million $1.03 Million
FCG Index = Free Cash Flow / Operating Cash Flow. FCF = Operating CF + Capital Expenditures (capex stored negative).